期刊
BIOLOGICAL PSYCHIATRY
卷 80, 期 5, 页码 356-362出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.biopsych.2015.12.021
关键词
Amygdala; Anxiety; CRHR1; FAAH; Habituation; Imaging genetics
资金
- Duke University
- National Institutes of Health (NIH) [R01-DA033369]
- NIH [T32-DA007313, T32-GM081739, R01-DA031579, R01-AG049789, R01-AG045231]
- Klingenstein Third Generation Foundation
BACKGROUND: Preclinical models reveal that stress-induced amygdala activity and impairment in fear extinction reflect reductions in anandamide driven by corticotropin-releasing factor receptor type 1 (CRF1) potentiation of the anandamide catabolic enzyme fatty acid amide hydrolase. METHODS: Here, we provide clinical translation for the importance of these molecular interactions using an imaging genetics strategy to examine whether interactions between genetic polymorphisms associated with differential anandamide (FAAH rs324420) and CRF1 (CRHR1 rs110402) signaling modulate amygdala function and anxiety disorder diagnosis. RESULTS: Analyses revealed that individuals with a genetic background predicting relatively high anandamide and CRF1 signaling exhibited blunted basolateral amygdala habituation, which further mediated increased risk for anxiety disorders among these same individuals. CONCLUSIONS: The convergence of preclinical and clinical data suggests that interactions between anandamide and CRF1 represent a fundamental molecular mechanism regulating amygdala function and anxiety. Our results further highlight the potential of imaging genetics to powerfully translate complex preclinical findings to clinically meaningful human phenotypes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据